These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15003295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 3. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J, Franco RS, Augsburger JJ, Banerjee RK.
    Curr Eye Res; 2007 Sep; 32(7-8):659-67. PubMed ID: 17852190
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
    Higuchi M, Hata T, Furuya S, Hosaka S, Kamijo Y, Kiyosawa K, Ishizuka O, Nishizawa O, Hora K.
    Nephrology (Carlton); 2005 Jun; 10(3):321-4. PubMed ID: 15958050
    [Abstract] [Full Text] [Related]

  • 6. [Primary central nervous system lymphoma in an immunocompetent patient: report of a case].
    Coronel F D, Gallardo V C, Gamargo G C.
    Rev Med Chil; 2008 Apr; 136(4):491-5. PubMed ID: 18769792
    [Abstract] [Full Text] [Related]

  • 7. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
    Ferreri AJ, Dell'Oro S, Capello D, Ponzoni M, Iuzzolino P, Rossi D, Pasini F, Ambrosetti A, Orvieto E, Ferrarese F, Arrigoni G, Foppoli M, Reni M, Gaidano G.
    Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
    Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U.
    Neurology; 2005 Apr 12; 64(7):1184-8. PubMed ID: 15824344
    [Abstract] [Full Text] [Related]

  • 9. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K, Arai A, Takase H, Takahashi H, Iwanaga Y, Sugamoto Y, Sugita S, Mochizuki M, Miura O.
    Rinsho Ketsueki; 2009 Mar 12; 50(3):182-6. PubMed ID: 19352085
    [Abstract] [Full Text] [Related]

  • 10. Primary central nervous system lymphoma: long-term survival following treatment with radiation and methotrexate.
    Petursson SR.
    Eur J Surg Oncol; 1989 Feb 12; 15(1):69-72. PubMed ID: 2645176
    [Abstract] [Full Text] [Related]

  • 11. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW.
    Clin Cancer Res; 2003 Feb 12; 9(2):711-5. PubMed ID: 12576439
    [Abstract] [Full Text] [Related]

  • 12. [Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
    Ohta M, Takeshita I, Matsumoto K, Matsuoka S, Ikeda K.
    No Shinkei Geka; 2005 Mar 12; 33(3):263-8. PubMed ID: 15773316
    [Abstract] [Full Text] [Related]

  • 13. [An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion].
    Kazahaya Y, Doi A, Hamaya K.
    No To Shinkei; 1992 Jan 12; 44(1):65-70. PubMed ID: 1562388
    [Abstract] [Full Text] [Related]

  • 14. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K, Urbach H, Helmstaedter C, Pels H, Glasmacher A, Kraus JA, Klockgether T, Schmidt-Wolf I, Schlegel U.
    Arch Neurol; 2003 Apr 12; 60(4):563-8. PubMed ID: 12707070
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J.
    Br J Ophthalmol; 2008 Mar 12; 92(3):383-8. PubMed ID: 18303160
    [Abstract] [Full Text] [Related]

  • 16. Implanted system for intraventricular drug infusion in central nervous system tumors.
    Dakhil S, Ensminger W, Kindt G, Niederhuber J, Chandler W, Greenberg H, Wheeler R.
    Cancer Treat Rep; 1981 Mar 12; 65(5-6):401-11. PubMed ID: 6263475
    [Abstract] [Full Text] [Related]

  • 17. Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy.
    Steinbeck JA, Stuplich M, Blasius E, Pels H, Glas M, Schlegel U, Herrlinger U.
    J Clin Neurosci; 2011 Nov 12; 18(11):1554-5. PubMed ID: 21868233
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T.
    Clin Pharmacol Ther; 2000 Jun 12; 67(6):631-41. PubMed ID: 10872645
    [Abstract] [Full Text] [Related]

  • 19. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR, Chowdhary S, Lombardi KM, Chalmers LM, Chamberlain M.
    Expert Rev Neurother; 2006 May 12; 6(5):635-52. PubMed ID: 16734512
    [Abstract] [Full Text] [Related]

  • 20. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Herrlinger U, Küker W, Uhl M, Blaicher HP, Karnath HO, Kanz L, Bamberg M, Weller M, Neuro-Oncology Working Group of the German Society.
    Ann Neurol; 2005 Jun 12; 57(6):843-7. PubMed ID: 15929034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.